Laurus Labs Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: LAURUSLABS BSE: 540222

₹1980.00

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #6 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited (this stock)	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹108,931 Cr

EV / EBITDA

64.6x

EV / Sales

16.98x

Market cap / Sales

16.68x

Earnings yield

0.82%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 1,777 Cr, up 22.2% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 290 Cr, up 83.6% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	1,757	388	290	₹5.3700
March 31, 2026	1,580	259	192	₹3.5500
Dec. 31, 2025	1,509	234	175	₹3.2500
Sept. 30, 2025	1,567	289	216	₹3.9900
June 30, 2025	1,433	211	158	₹2.9300
March 31, 2025	1,650	330	252	₹4.6800
Dec. 31, 2024	1,265	77	57	₹1.0600
Sept. 30, 2024	1,185	58	42	₹0.7900
June 30, 2024	1,117	39	29	₹0.5300
March 31, 2024	1,415	164	121	₹2.2500
Dec. 31, 2023	1,132	57	43	₹0.7900
Sept. 30, 2023	1,158	63	47	₹0.8700
June 30, 2023	1,108	17	13	₹0.2400

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	1,777	1,593	1,524	1,595	1,454	1,722	1,272	1,197	1,126	1,439	1,143	1,164	1,114
Operating revenue	1,757	1,580	1,509	1,567	1,433	1,650	1,265	1,185	1,117	1,415	1,132	1,158	1,108
Other income	20	13	14	28	22	72	7	12	9	24	11	6	7
Operating expenses	1,258	1,205	1,164	1,177	1,105	1,255	1,059	1,003	956	1,143	962	978	980
Operating profit	499	375	346	390	327	395	206	182	161	271	170	181	128
Operating profit margin	28.4%	23.8%	22.9%	24.9%	22.8%	23.9%	16.3%	15.3%	14.4%	19.2%	15.0%	15.6%	11.5%
Depreciation	96	95	94	96	94	88	89	91	91	89	87	85	84
Interest	35	34	31	34	44	49	48	45	41	42	38	38	33
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	388	259	234	289	211	330	77	58	39	164	57	63	17
Tax	98	68	59	73	54	78	19	16	10	43	14	17	4
Net profit	290	192	175	216	158	252	57	42	29	121	43	47	13
EPS	5.37	3.55	3.25	3.99	2.93	4.68	1.06	0.79	0.53	2.25	0.79	0.87	0.24
Net profit (TTM)	872	740	801	683	510	380	250	235	239	224	205	389	574
EPS (TTM)	16.16	13.72	14.85	12.66	9.46	7.06	4.63	4.36	4.44	4.15	3.79	7.23	10.67

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	6,089	994	740
March 31, 2025	5,217	504	380

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
Total income (before exceptional items)	—	5.2%	6,166^†	5,317^†	4,860^†	4,729^†	4,796^†	2,807^†	2,252^†	2,068^†
Operating revenue	—	5.0%	6,089	5,217	4,812^†	4,707^†	4,769^†	2,797^†	2,236^†	2,039^†
Other income	—	—	77^†	100^†	47^†	22^†	27^†	9^†	16^†	29^†
Operating expenses	—	—	4,651^†	4,273^†	4,063^†	3,422^†	3,259^†	2,231^†	1,885^†	—
Operating profit	—	-1.0%	1,438^†	944^†	750^†	1,285^†	1,510^†	567^†	351^†	—
Operating profit margin	—	—	23.6%^†	18.1%^†	15.6%^†	27.3%^†	31.7%^†	20.3%^†	15.7%^†	—
Depreciation	—	—	379^†	359^†	345^†	235^†	197^†	184^†	161^†	—
Interest	—	—	143^†	182^†	151^†	96^†	66^†	88^†	86^†	75^†
Exceptional items, gain / (loss)	—	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	—	-4.9%	994	504	301^†	975^†	1,275^†	304^†	121^†	245^†
Tax	—	—	254^†	123^†	78^†	225^†	319^†	37^†	26^†	68^†
Net profit	—	-5.0%	740	380	224^†	750^†	956^†	267^†	95^†	178^†
EPS	—	-14.3%	13.72^†	7.06^†	4.15^†	13.97^†	29.73^†	25.03^†	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
Operating margin	23.6%^†	18.1%^†	15.6%^†	27.3%^†	31.7%^†	20.3%^†	15.7%^†	—
EBIT margin	18.7%^†	13.1%^†	9.4%^†	22.8%^†	28.1%^†	14.0%^†	9.3%^†	15.7%^†
PBT margin	16.3%	9.7%	6.3%^†	20.7%^†	26.7%^†	10.9%^†	5.4%^†	12.0%^†
Net margin	12.2%	7.3%	4.6%^†	15.9%^†	20.0%^†	9.5%^†	4.2%^†	8.7%^†
Interest coverage	7.95x^†	3.77x^†	3.00x^†	11.18x^†	20.34x^†	4.47x^†	2.41x^†	4.25x^†
Dividend payout	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—
Current ratio	1.34x	1.27x	—	—	—	—	—	—
Quick ratio	0.68x	0.72x	—	—	—	—	—	—
Debt to equity	0.38x	0.51x	—	—	—	—	—	—
Return on equity	14.1%	8.3%	—	—	—	—	—	—
Return on assets	7.8%	4.4%	—	—	—	—	—	—
Return on capital employed	18.1%^†	12.6%^†	—	—	—	—	—	—
Asset turnover	0.64x	0.61x	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	1,385	-847	-551	714	671
March 31, 2025	540	-592	59	381	159

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	9,540	5,252	5,144	1,621	378	4,363	3,258	38	2,893	2,136
March 31, 2025	8,587	4,564	4,456	1,910	414	4,007	3,162	50	2,763	1,739

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.